Exploring Kohima — a slow traveller’s delight
For this first-time visitor, the Naga capital city unfolded like a cold night’s dream offering stories of history, culture, ...
RDY Launches Loqtorzi Biosimilar in India for Nasopharyngeal Carcinoma
Dr. Reddy's launches Loqtorzi biosimilar in India under the brand name Zytorvi for treating adults with recurrent or ...
Government making continuous effort to promote IT industry in small cities and towns
The Government of India is making continuous efforts to promote IT industry in smaller cities and towns and has initiated multiple schemes and programmes for growth of IT industry in this regard. The ...
Business Line1d
Dr Reddy’s launches nasopharyngeal carcinoma drug Toripalimab in India
Dr. Reddy’s will market it under the brand name Zytorvi in India ... The highest age-adjusted rates for NPC were found in the ...
The Financial Express1d
Dr. Reddy’s launches first immuno-oncology drug to treat rare form of head and neck cancer in India
Nasopharyngeal carcinoma (NPC) is a rare, aggressive form of head and neck cancer that originates in the nasopharynx, the ...
Dr. Reddy's launches Toripalimab in India to treat rare form of head & neck cancer
Hyderabad, November 28 (IANS): Dr. Reddy’s Laboratories on Thursday announced the launch of Toripalimab in India to treat ...
Equity Bulls17h
Dr. Reddy's launches Toripalimab in India, the first and only immuno-oncology drug approved for the treatment of nasopharyngeal carcinoma
Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY; along with its subsidiaries together referred to as "Dr. Reddy's"), announced the launch of Toripalimab in India.
Dr Reddy’s launches India’s first immuno-oncology drug to treat rare form of head and neck cancer
With this launch, India has become the third country in the world, after China and the US, to receive access to this ...
Shillong Times1d
Economics from the common (wo)man’s perspective
American scholar Eric Zency who uses the principles of ecological economics has come up with a model he called the Genuine Progress Indicator (GPI) which he says needs to replace the GDP. And looking ...
Pharmabiz1d
Dr Reddy's launches toripalimab in India for the treatment of nasopharyngeal carcinoma
Dr Reddy's launches toripalimab in India for the treatment of nasopharyngeal carcinoma: Our Bureau, Bengaluru Thursday, November 28, 2024, 12:15 Hrs [IST] Dr Reddy’s Laboratorie ...